FEB 052018
12 new patents,
Sr no
|
Patent number
|
name
|
company
|
INDICATION
|
REMARKS, WAIT FOR STR TO APPEAR
|
1
|
WO-2018023009
|
LURASIDONE
|
CONCERT
|
Bipolar I disorder; Schizophrenia
| |
2
|
WO-2018022704
|
SELEXIPAG
|
TEVA
| Pulmonary artery hypertension | |
3
|
WO-2018021818
|
FEBUXOSTAT
|
HANMI
|
Gout; Hyperuricemia; Tumor lysis syndrome
| |
4
|
WO-2018021517
|
AMISELIMOD
|
MITSUBISHI
|
Autoimmune disease; Crohns disease; Inflammatory bowel disease; Multiple sclerosis; Psoriasis
| |
5
| WO-2018020506 |
CANAGLIFLOZIN
|
NATCO
|
Non-insulin dependent diabetes
| |
6
|
WO-2018020450
|
ELUXADOLINE
|
LUPIN
| Diarrhea predominant irritable bowel syndrome | |
7
|
WO-2018020406
|
BELINOSTAT
|
FRASENIUS
|
CANCER
| |
8
|
WO-2018020380
|
DOLUTEGRAVIR
|
LUPIN
|
HIV infection
| |
9
| WO-2018020366 |
TRANYLCYPROMINE
|
GSK
|
Depression; Parkinsons disease
| |
10
|
WO-2018019549
|
OMACETAXINE
|
INDENA
| Chronic myelocytic leukemia | |
11
|
WO-2018019196
|
IXAZOMIB
|
SHENZEN
|
CANCER
| |
12
| WO-2018018986 |
CERITINIB
|
ARROMAX
|
Cardiovascular disease; Infectious disease; Inflammatory disease; Metabolic disorder; Viral infection
| |
13
| |||||
14
| |||||
15
| |||||
16
| |||||
